Cognetivity Neurosciences Ltd
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Co… Read more
Market Cap & Net Worth: Cognetivity Neurosciences Ltd (CGNSF)
Cognetivity Neurosciences Ltd (PINK:CGNSF) has a market capitalization of $179.18K ($179.18K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45133 globally and #14223 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cognetivity Neurosciences Ltd's stock price $0.00 by its total outstanding shares 89588611 (89.59 Million).
Cognetivity Neurosciences Ltd Market Cap History: 2018 to 2025
Cognetivity Neurosciences Ltd's market capitalization history from 2018 to 2025. Data shows change from $25.84 Million to $179.18K (-54.80% CAGR).
Cognetivity Neurosciences Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cognetivity Neurosciences Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
29.62x
Cognetivity Neurosciences Ltd's market cap is 29.62 times its annual revenue
1.54x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $1.34 Million | $45.37K | -$7.43 Million | 29.62x | N/A |
Competitor Companies of CGNSF by Market Capitalization
Companies near Cognetivity Neurosciences Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Cognetivity Neurosciences Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Cognetivity Neurosciences Ltd Historical Marketcap From 2018 to 2025
Between 2018 and today, Cognetivity Neurosciences Ltd's market cap moved from $25.84 Million to $ 179.18K, with a yearly change of -54.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $179.18K | -50.00% |
| 2024 | $358.35K | -73.33% |
| 2023 | $1.34 Million | -91.57% |
| 2022 | $15.95 Million | -58.60% |
| 2021 | $38.52 Million | -10.75% |
| 2020 | $43.16 Million | +188.68% |
| 2019 | $14.95 Million | -42.13% |
| 2018 | $25.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cognetivity Neurosciences Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $179.18K USD |
| MoneyControl | $179.18K USD |
| MarketWatch | $179.18K USD |
| marketcap.company | $179.18K USD |
| Reuters | $179.18K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.